Evidence-Based Care for Multiple Sclerosis
Earlier in 2022, a study by Alberto Ascherio, MD, DrPH and colleagues that included data on more than 10 million young adults on active duty in the U.S. military, suggested that participants infected with the Epstein- Barr (EBV) had a 32-fold increased risk of developing multiple sclerosis (MS), with no increase seen after infection with other viruses, including similarly transmitted cytomegalovirus.1 The results have since reignited the debate around the root cause of MS, and the NIH has launched a clinical trial to evaluate a possible EBV vaccine.2
In addition to this potentially revolutionary discovery, the field of MS care has advanced in both its therapeutic offerings and imaging capabilities. The advances that have been made have greatly improved the prognostic outlook for patients, but have also somewhat complicated conversations with patients.
Improved communication of these advances and discoveries has been achieved through education and peer-to-peer information sharing. NeurologyLive® State of Science Summit events are short meetings aimed at providing these opportunities. Designed to educate neurologists and advanced practice clinicians about the clinical benefits associated with new science fueling new thinking, our renowned faculty focuses on the topics most relevant to improving patient care, including overcoming disparities and caring for specific patient populations.
This event, chaired by Robert T. Naismith, MD, professor of neurology at Washington University in St. Louis, is taking place virtually from 6:30-8:00 p.m. CST on Thursday, November 3, 2022. Register today at no cost to get access to the program, featuring various presentations on key aspects of treatment and advances in understanding MS, including insights from other experts at Washington University in St. Louis: Salim Chahin, MD, MSCE; Anne H. Cross, MD; Gregory F. Wu, MD, PhD; and Matthew R. Brier, MD, PhD.
Additionally, the event will feature a pair of Q&A sessions for open discussion on the presentation topics. Registration for this virtual event is free, and neurologists and advanced practice clinicians are encouraged to share their feedback in our post-event survey.
Presentation topics include:
- Case presentation: Evidence-based MS care —Robert T. Naismith, MD
- Choosing a DMT — Salim Chahin, MD, MSCE
- Pros: Epstein-Barr virus causes multiple sclerosis —Anne H. Cross, MD
- Disadvantage: Epstein-Barr virus causes multiple sclerosis —Gregory F. Wu, MD, PhD
- Clinical neuroimaging in MS: more than counting lesions —Matthew R. Brier, MD, PhD.
For information on other events, see our Institutional Insights in Neurology: Multiple Sclerosis page.